This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier Provides Access To Reaxys® For Five Czech Universities To Optimize Their Research In Chemistry

PRAGUE, June 3, 2013 /PRNewswire/ --

5-Year Access Agreement Supported by the European Structural Funds' Operational Framework Program for Research, Development and Innovation

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced it has provided access to Reaxys , an online workflow solution for research chemists, for five Czech universities: the University of Pardubice, the Masaryk University, the Palacky University in Olomouc, the Tomas Bata University in Zlín and the University of Veterinary and Pharmaceutical Sciences Brno. The 5-year access agreement is supported by the European Structural Funds (ESF) through their Operational Framework Program for Research, Development and Innovation.

"The Czech Republic does not have an optimal solution to support the need for sustainable access to high quality global scientific research information for all its universities," said Prof. Ing. Miroslav Ludwig, CSc, Rector of the University of Pardubice. "Funding from European Structural Funds to help secure access to basic information infrastructure in chemistry, chemical engineering and other related fields connected with sustainable development, opens doors to change this situation".

Ms. Prochaskova, project coordinator of the Chemical Electronic Information Resources for R&D project at the University Pardubice said, "Reaxys' content includes some of the most important information resources for chemistry and related fields. We are very pleased that access to Reaxys forms an essential part of the project and has been secured for these five Czech universities for the next five years."

Lucie Vavrikova, Elsevier's Country Manager for Czech Republic added, "We are very happy to support these universities by providing them with access to Reaxys. It is also worth mentioning that financing from the European Structural Funds to expand access to electronic resources such as Reaxys could also support other Central and Eastern European countries in their desire to improve their research performance."

Reaxys is a unique workflow solution for researchers across all chemistry related domains. It is a key pillar of Elsevier Life Science Solutions, a suite of interoperable, domain-specific workflow solutions.

About Reaxys®

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%
TSLA $222.56 -4.20%
YHOO $36.00 -0.03%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs